CEOs walk a fine line when it comes to talking about hot-button issues like transgender rights or gun control or arming transgender people to fight for the right of immigrants to have affordable health care and equal pay without enduring global warming.
July 29, 12:23 PM
What would you do if you had $50 billion? You'd probably buy everything you've ever wanted, but you still wouldn’t be able to spend all the money on yourself. Figuring out how to spend all that money would be your biggest problem. I mean, how many cars can you have? How many houses can you own? It’s pretty finite, right?
May 31, 3:55 PM
Cybin Inc. (CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics," has submitted an Investigational New Drug (or “IND”) application to the FDA.
May 26, 1:37 PM
The meeting, which took place on May 18 between the psychedelic pharmaceutical biotech company Clearmind Medicine Inc. (CMNDF) and the US Food and Drug Administration marks the completion the pre-IND New Drug Application stage.
May 24, 3:21 PM
The Efficient-Market Hypothesis (EMH) is a popular theory within the world of finance. The idea behind EMH is that the stock market is "informationally efficient," meaning that a stock is always accurately valued at any given time based on the information that is publicly available about that stock.
May 19, 1:13 PM
After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychotherapy or KAP, for frontline workers, at some of its clinics.
May 12, 7:45 AM
Field Trip Health (NASDAQ: FTRP), a company offering mental health treatment using ketamine therapy, has inked a unique deal with Nue Life Health to expand its service offerings to at-home treatment.
May 6, 4:15 PM
... or any stock, commodity or currency for that matter. Risk management is crucial. It is the difference between growing and blowing an account and how quickly.